Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

48

Revenue 2017

Crestor

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Crestor was produced by AstraZeneca and Shionogi.

This month in 1989: the creation of Bristol-Myers Squibb

This month in 1989: the creation of Bristol-Myers Squibb For Squibb, many of its sales depended on Capoten (captopril), an ace inhibitor that dominated a pre-Lipitor/Crestor hypertension market.

Back to the future

Back to the future Only Seretide/Advair ($8.4bn), Abilify ($8bn) and Crestor ($6.9bn) prevented a biologic clean sweep of the bestsellers.

Pfizer rumoured to be after AstraZeneca

Pfizer rumoured to be after AstraZeneca Meanwhile, Pfizer has started to emerge from a patent cliff while AZ is still facing expirations on key earners such as gastrointestinal therapy Nexium (esomeprazole) and cholesterol-lowerer Crestor (rosuvastatin).

Soriot says pipeline will speed recovery at AZ

Soriot says pipeline will speed recovery at AZ Fourth-quarter revenues came in at $6.84bn, down 6 per cent, as generics continued to drag down several top-selling products, including cholesterol treatment Crestor (rosuvastatin) and gastrointestinal drug Nexium ... Analysts said the 8 per cent fall

VCCP Health takes lead at PM Society Awards

VCCP Health takes lead at PM Society Awards Crestor for AstraZeneca by Saatchi &Saatchi Health (Joint Winner). I did this with Idis for Idis by Langland (Joint Winner).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...